Personal Genome Diagnostics, a leading cancer genomics company and pioneer in liquid biopsy, today announced that PGDx elio™ plasma resolve has received Breakthrough Device designation from...
Read More »Personal Genome Diagnostics, a leading cancer genomics company and pioneer in liquid biopsy, today announced that PGDx elio™ plasma resolve has received Breakthrough Device designation from...
Read More »